Filing Details
- Accession Number:
- 0001127602-19-002842
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-29 08:20:58
- Reporting Period:
- 2019-01-25
- Accepted Time:
- 2019-01-29 08:20:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-25 | 7,054 | $52.65 | 7,194 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-25 | 200 | $113.42 | 6,994 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-25 | 3,001 | $114.64 | 3,993 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-25 | 3,853 | $115.66 | 140 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-01-28 | 7,054 | $52.65 | 7,194 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-28 | 700 | $114.43 | 6,494 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-28 | 3,427 | $115.33 | 3,067 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-28 | 2,927 | $116.13 | 140 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2019-01-25 | 7,054 | $0.00 | 7,054 | $52.65 |
| Common Stock | Stock Options | Disposition | 2019-01-28 | 7,054 | $0.00 | 7,054 | $52.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 42,326 | 2009-12-31 | 2019-12-31 | No | 4 | M | Direct |
| 35,272 | 2009-12-31 | 2019-12-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 166 | Indirect | By Spouse |
| Common Stock | 683,489 | Indirect | By Trusts |
Footnotes
- This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan (the "plan") entered into by the reporting person. The plan is designed to exercise and sell up to 148,138 stock options (which expire at the end of 2019) during the month of January 2019, in equal tranches of approximately 7,055 shares per day assuming certain conditions are met.
- This transaction was executed in multiple trades at prices ranging from $112.935 to $113.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $114.00 to $114.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $115.13 to $115.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $113.66 to $114.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $114.75 to $115.69. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $115.75 to $116.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
